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Abstract
Given a compound, how can we effectively predict its biological function? It is a fundamentally important problem because
the information thus obtained may benefit the understanding of many basic biological processes and provide useful clues
for drug design. In this study, based on the information of chemical-chemical interactions, a novel method was developed
that can be used to identify which of the following eleven metabolic pathway classes a query compound may be involved
with: (1) Carbohydrate Metabolism, (2) Energy Metabolism, (3) Lipid Metabolism, (4) Nucleotide Metabolism, (5) Amino Acid
Metabolism, (6) Metabolism of Other Amino Acids, (7) Glycan Biosynthesis and Metabolism, (8) Metabolism of Cofactors and
Vitamins, (9) Metabolism of Terpenoids and Polyketides, (10) Biosynthesis of Other Secondary Metabolites, (11) Xenobiotics
Biodegradation and Metabolism. It was observed that the overall success rate obtained by the method via the 5-fold cross-
validation test on a benchmark dataset consisting of 3,137 compounds was 77.97%, which is much higher than 10.45%, the
corresponding success rate obtained by the random guesses. Besides, to deal with the situation that some compounds may
be involved with more than one metabolic pathway class, the method presented here is featured by the capacity able to
provide a series of potential metabolic pathway classes ranked according to the descending order of their likelihood for
each of the query compounds concerned. Furthermore, our method was also applied to predict 5,549 compounds whose
metabolic pathway classes are unknown. Interestingly, the results thus obtained are quite consistent with the deductions
from the reports by other investigators. It is anticipated that, with the continuous increase of the chemical-chemical
interaction data, the current method will be further enhanced in its power and accuracy, so as to become a useful
complementary vehicle in annotating uncharacterized compounds for their biological functions.
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Introduction
Metabolism refers to a collection of chemical reactions in vivo,
which keep an unceasing supply of matter and energy for living
organisms to maintain life (e.g., growth and reproduction) [1].
These energy-using and energy-releasing chemical reactions
catalyzed by enzymes are organized into many metabolic
pathways. Some compounds/small molecules play major roles in
these pathways and are vital for many activities essential for life.
For example, during the digestion, the energy rich molecules (i.e.
carbohydrate) are broken apart to provide energy, which is then
used by cells to build up complex molecules from simple
molecules, such as utilizing amino acids to synthesize new proteins
that the body needs. Identifying the biological functions of
compounds is an effective way to study the mechanisms of many
basic biological processes [2]. On the other hand, small molecules
are the cause, and the cure, for many diseases. For example,
diabetes mellitus is a metabolic disease caused by insufficient or
inefficient insulin secretary response and elevated blood glucose
level [3]. Compounds such as sulfonylureas [4], acarbose [5],
biguanides, thiazolidinediones [5], and sitagliptin [3] have been
used as effective drugs for diabetic therapy. Therefore, it is
essential to annotate the bioactivities of compounds, which will
benefit drug design and disease treatment.
Besides the conventional biochemical experiments, computa-
tional methods are alternative ways to annotate the biological
functions of compounds. In recent years, various bioinformatics
and structural bioinformatics [6] tools were developed to address
this issue, such as Quantitative Structure Activity Relationship
(QSAR) [7,8], pharmacophore modeling [9], molecular docking
[10], and Monte Carlo simulated annealing approach [11,12].
Different from these methods, Lu et al. [1] and Cai et al. [2]
analyzed the biological functions of compounds by mapping them
to the corresponding metabolic pathway classes, which are
strongly associated with the biological functions of compounds.
The functional group composition was used to represent the
compounds, and the Nearest Neighbor Algorithm and AdaBoost
learner [13] were used to construct the prediction models by Cai et
al. [2] and Lu et al. [1], respectively. Both the two prediction
methods achieved quite promising results on their own datasets.
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compounds that belong to two or more metabolic pathway classes.
Since these authors were only focused on addressing the single-
label classification problem, their methods could not be used to
deal with the ‘‘multi-function’’ compounds. Actually, according to
KEGG [14], among all the compounds with functional annota-
tions, the ‘‘multi-function’’ compounds occupy about 8%.
Particularly, these multi-function compounds may play some
unique role intriguing to both basic research and drug develop-
ment and hence are worthy of our special attention.
Recently, the systems biology methods based on protein-protein
interactions have been widely applied for predicting protein
attributes [15,16,17,18,19]. These algorithms suggest that inter-
active proteins are likely to share the common biological functions
[16,17,18,19], also more likely tending to have the same biological
function than non-interactive ones [20,21]. Likewise, we can
assume that the interactive compounds may tend to share the
common biological functions. In this study, the chemical-chemical
interactions were retrieved from STITCH [22] (Search tool for
interactions of chemicals), where the interaction unit consists of
two chemicals and their interaction weight. The interaction weight
(confidence score) represents the probability that the interaction
occurs between the two chemicals concerned. The interactive
compounds can be classified into the following three categories: (I)
ones that participate in the same reactions; (II) ones that share the
similar structures or activities; (III) ones with the literature
associations [22]. In a metabolism system, chemical reactions are
organized into many metabolic pathways, thus the compounds
involved in the same reactions are in the same metabolic
pathways. Similar structures or activity means that they share
the similar functions, and hence they are likely to be in the same
metabolic pathways. The co-occurrence of two compounds in
many literatures suggests some kinds of direct or indirect
relationships, indicating they have the potential to be in the same
metabolic pathways. Accordingly, it is rational to suppose that the
interactive compounds tend to participate in the same metabolic
pathways.
In this study, we proposed a multi-target model based on
chemical-chemical interactions for predicting the metabolic
pathways where compounds participate in. Our method sorts
the possible metabolic pathways that are associated with the query
chemical, providing a more comprehensive view of the biological
effects of the compound.
According to a recent comprehensive review [23], to establish
a really useful statistical predictor for a biological system, we
need to consider the following procedures: (1) construct or select
a valid benchmark dataset to train and test the predictor; (2)
formulate the statistical samples with an effective mathematical
expression that can truly reflect their intrinsic correlation with
the attribute to be predicted; (3) introduce or develop a powerful
algorithm (or engine) to operate the prediction; (4) properly
perform cross-validation tests to objectively evaluate the
anticipated accuracy of the predictor. Below, let us describe
how to deal with these steps.
Materials and Methods
Benchmark Dataset
The compounds were retrieved from public available database
KEGG [14] (Kyoto Encyclopedia of Genes and Genomes)
compound [ftp://ftp.genome.jp/pub/kegg/release/archive/
kegg/42/ligand.tar.gz] (release 42.0). Subsequently, these com-
pounds were mapped to the following 11 major metabolic
pathway classes that are strongly associated with the biological
functions of compounds (http://www.genome.jp/kegg/pathway.
html#metabolism): (1) Carbohydrate Metabolism, (2) Energy
Metabolism, (3) Lipid Metabolism, (4) Nucleotide Metabolism,
(5) Amino Acid Metabolism, (6) Metabolism of Other Amino
Acids, (7) Glycan Biosynthesis and Metabolism, (8) Metabolism
of Cofactors and Vitamins, (9) Metabolism of Terpenoids and
Polyketides, (10) Biosynthesis of Other Secondary Metabolites,
(11) Xenobiotics Biodegradation and Metabolism. After exclud-
ing those compounds without any metabolic pathway informa-
tion, 4,366 compounds were collected that have clear biological
functions annotated (see Table 1 under the title of Group-I).
From the 4,366 compounds of Group-I, 3,137 compounds were
retrieved that can interact with any of the others as annotated
by STITCH database [22] (see Table 1 under the title of
Group-II).
Of the 4,366 compounds of Group-I, 4,027 are involved in only
one metabolic pathway class, 246 in two metabolic pathway
classes, 54 in three metabolic pathway classes, 24 in four metabolic
pathway classes, 9 in five metabolic pathway classes, 4 in six
metabolic pathway classes, 2 in seven metabolic pathway classes,
and none in eight or more metabolic pathway classes. Of the 3,137
compounds of Group-II, 2,820 are involved in only one metabolic
pathway class, 226 in two metabolic pathway classes, 53 in three
metabolic pathway classes, 23 in four metabolic pathway classes, 9
in five metabolic pathway classes, 4 in six metabolic pathway
classes, 2 in seven metabolic pathway classes, and none in eight or
more metabolic pathway classes.
Note that since one compound may occur in more than one
pathway class, the sum of the compounds over the 11 pathway
classes in Group-I turns out to be 4,860, which is greater than
4,366. Likewise, the sum of the compounds over the 11 pathway
classes in Group-II is 3,606, which is greater than 3,137. This is
quite similar to the case of proteins with multiple location sites, as
elaborated in [24,25].
The chemicals interactions were retrieved from STITCH [22],
a large database of known and predicted interactions of chemicals
and proteins derived from experiments, literature, databases, and
so on. As mentioned in Introduction, there are three types of
associations between two compounds in STITCH: (I) co-
occurrence in reactions, (II) similar structures or activities, and
(III) literature associations. In the downloaded STITCH chemicals
interactions file: chemical_chemical.links.detailed.v2.0.tsv from
http://stitch.embl.de/cgi/show_download_page.pl, there are
337,482 pairs of interactive compounds belonging solely to type
I, 73,598 pairs solely in type II, 2,152,508 pairs solely in type III,
384 pairs in both type I and II, 120,936 pairs in both type I and
III, 10,372 pairs in both type II and III, and 1,990 pairs in the
three types, in total of 2,697,270 interactions. Each of the
interaction is quantified by the interaction confidence score, which
represents the likelihood that the interaction occurs. In this study,
the interactions with both interactive compounds occurring in the
4,366 compounds of Group-I were extracted. As a result, 3,137
compounds with 75,949 interactions were collected to constitute
the benchmark dataset of the current study (see Table 1 under the
title of Group-II).
Besides the 4,366 compounds (cf. Table 1 under the title of
Group-I) with known metabolic pathway classes, there are
11,661 compounds without known metabolic pathway classes in
KEGG. Among these compounds, 5,549 compounds that have
annotated interactions with the compounds of the 4,366
compounds in STITCH were collected. Such 5,549 compounds
are to form an independent dataset, being used to test our
prediction method in hopes to acquire useful information for
further investigation.
Predicting Compounds’ Biological Functions
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As mentioned in Introduction, the interactive compounds tend to
participate in the same metabolic pathways. Accordingly, for a query
compound, thehigher interaction confidence score with itsinteractive
compound, the more likely they are to participate in the same
metabolic pathway. The more its interactive compounds involving in
a certainmetabolic pathway,the morelikely it is to participate in such
metabolic pathway. Based on these points, we should count not only
the number of compounds interacting with the query compound, but
also the corresponding interaction scores. Thus, the desired predictor
can be formulated via the following procedures.
Suppose the training dataset contains n compounds, which are
denoted as fC1,C2,:::,Cng. The 11 metabolic pathway classes (cf.
Table 1) are expressed as fP1,P2,:::,P11g, where P1 represents
the 1
st metabolic pathway class (‘‘Carbohydrate Metabolism’’), P2
the 2
nd metabolic pathway class (‘‘Energy Metabolism’’), P3 the
3
rd metabolic pathway class (‘‘Lipid Metabolism’’), and so forth.
Thus, the descriptor of metabolic pathway classes to which the
compound Ci belongs to can be formulated as
P(Ci)~½pi,1,pi,2,:::,pi,j,:::,pi,11 
T (i~1,2,:::,n;j~1,2,:::,11) ð1Þ
where
pi,j~
1, if Ci belongs to metabolic pathway class Pj
0, otherwise
 
ð2Þ
Given a query compound Cq, its interaction with the compounds
in the training dataset can be defined as
W(Cq)~½wq,1,wq,2,:::,wq,i,:::,wq,n 
T ð3Þ
where wq,i represents the interaction confidence score between Cq
and Ci. T is the transpose operator, and wq,i~0 if no interaction
exists between them. Here, we did not consider the self-
interaction, therefore wq,i~0 when q~i. Accordingly, the
likelihood that the query compound Cq is involved in the j-th
metabolic pathway class can be formulated by the following score
S(Cq[j)~
Pn
i~1 wq,ipi,j (j~1,2,:::,11) ð4Þ
which is the sum of the interaction confidence scores of Cq with its
interactive compounds in the training dataset by counting both the
number of interactive compounds and the interaction confidence
scores. Obviously,thehigherthescoreofEq.4,the morelikely Cq is
to be involved in the j-th metabolic pathway Cj. Thus, for a given
querycompoundCq,wecanuseEq.4tocalculateits11scores,with
each associated with one of the 11 metabolic pathway classes. The
class to which the compound Cq most likely belongs should be the
one with the highest score. In other words, the query compound Cq
will be predicted to belong to the mth metabolic pathway class if
m~arg maxj S(Cq[j)jj~1,2,:::,11
  
ð5Þ
where m is the argument of j that maximize the value of S(Cq[j).
Since the problem in this study is of multi-label classification, we
intend to provide flexible information by predicting some candidate
metabolic pathway classes for the query compounds, rather than
just the most likely metabolic pathway class. Therefore, instead of
Eq. 5, let us consider the following equation containing 11 scores in
a one-column vector:
D; S(Cq[j)jj~1,2,:::,11
  
~V~
S1
S2
. .
.
Sj
. .
.
S10
S11
2
6 6 6 6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 7 7 7 5
ð6Þ
Table 1. Distribution of the 4,366 and 3,137 compounds in the 11 metabolic pathway classes.
Class code Metabolic Pathway Number of different compounds
Group-I Group-II
4,366 3,137
1 Carbohydrate Metabolism 444 394
2 Energy Metabolism 129 120
3 Lipid Metabolism 610 383
4 Nucleotide Metabolism 145 132
5 Amino Acid Metabolism 563 483
6 Metabolism of Other Amino Acids 212 154
7 Glycan Biosynthesis and Metabolism 68 43
8 Metabolism of Cofactors and Vitamins 396 309
9 Metabolism of Terpenoids and Polyketides 713 499
10 Biosynthesis of Other Secondary Metabolites 722 519
11 Xenobiotics Biodegradation and Metabolism 858 570
Overall 4,860 3,606
The 4,366 compounds in Group-I were screened from KEGG by selecting the compounds with the metabolic pathway information. The 3,137 compounds in Group-II were
those retrieved from the 4,366 compounds that can interact with any other as annotated by STITCH database. Note that since a compound may occur in more than one
pathway class, the sum of the compounds over the 11 pathway classes is greater than the number of different compounds for the cases of both Group-I and Group-II.
doi:10.1371/journal.pone.0029491.t001
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S(Cq[j) according to the descending order (S1§S2§   
§Sj§   §S11) .I ft h e r ei sat i ea m o n gt h e s es c o r e s ,ar a n d o m
order will be made among those with a tie. Consequently, the
predicted metabolic pathway classes for the query compound can be
derived according to the descending order of Eq. 6; i.e., if
S1~S(Pk[6), S2~S(Pk[1), S3~S(Pk[10), then it follows
that the query compound Cq is involved in the 6
th metabolic pathway
class (‘‘Metabolism of Other Amino Acids’’) will be ranked as the
highest in the likelihood, that Cq in the 1
st metabolic pathway class
(‘‘Carbohydrate Metabolism’’) as the 2
nd,a n dt h a tCq in the 10
th
metabolic pathway class (‘‘Biosynthesis of Other Secondary Metab-
olites’’) as the 3
rd. The corresponding results thus obtained are,
respectively, called the 1
st-order, 2
nd-order, and 3
rd-order predicted
metabolic pathway classes. And so forth.
Cross-Validation
In statistical prediction, the following three cross-validation
methods are often used to examine a predictor for its effectiveness
in practical application: independent dataset test, subsampling
(such as 5-fold, 7-fold, or 10-fold cross-validation) test, and
jackknife test [26]. In this study, the 5-fold cross-validation was
employed to examine the performance of our method. The
concrete procedures were that the training dataset were divided
into five groups by splitting each of its subsets into five
approximately equal-sized subgroups. Each of these five groups
was in turn used as a testing dataset and the rest used as training
dataset, thereby generating five different success rates, with their
average representing the success rate by the 5-fold cross-validation.
For the j-th order prediction, the accuracy Wj was calculated by
Wj~
Mj
N
(j~1,2,:::,11) ð7Þ
where Mj is the number of the compounds whose j-th order
predicted metabolic pathway class is one of the true pathway
classes that the compounds are involved with, and N is the total
number of compounds in the dataset. Such 11-order accuracies
were used to evaluate our prediction method. It is obvious
according to the definition of Eq. 7 that, the higher the value of Wj
with a smaller value of j, or the lower the value of Wj with a larger
value of j, the better the prediction quality will be by our method.
In the dataset, the average number of metabolic pathway class
that each compound is involved in is calculated as
H~
P N
i~1
Ei
N
ð8Þ
where Ei is the number of metabolic pathway classes that the
compound Ci is involved with. Hence, another measurement - the
likelihood that the first k order predicted metabolic pathway classes
cover all the true metabolic pathway classes that the compound is
involved in – can be formulated as
Lk~
P k
x~1
Wx
P 11
j~1
Wj
ð9Þ
Usually, k is the smallest integer equal or greater than the average
number of metabolic pathway classes (H). It is obvious from Eq. 9
that the larger the value of Lk, the better the prediction quality will
be by our method.
Prediction process
Given a query compound, according to the information of its
interactions with the 4,366 compounds in Group-I (Table 1)
whose metabolic pathway classes are known, the likelihood of its
belonging to each of the 11 metabolic pathway classes can be
easily calculated according to Eq. 4. And the scores thus obtained
were sorted according to a descending order (Eq. 6) to yield the
predicted metabolic pathway classes according to their different
ranks or orders.
Results and Discussion
Evaluation Results by the 5-fold Cross-validation
In this study, our method was evaluated by the 5-fold cross-
validation on the benchmark dataset that contains 3,137
compounds in Group-II of Table 1. The 11-order prediction
accuracies are shown in Figure 1. The first order (most likely)
prediction accuracy is 77.97%, and the last order (least likely)
prediction accuracy is 0.38%, which indicates a quite good
performance of our method.
The average number of metabolic pathway classes with which
each compound is involved is 1.15 (cf. Eq. 8), meaning that the
average success rate by a random guess would be 1.15/
11=10.45%, which is much lower than that by our method.
Accordingly, the parameter k in Eq. 9 was set to (1.15+1)=2;
i.e., we may select the results of the first two orders of the predicted
metabolic pathway classes for the query compounds. As we can see
from Figure 1, the accuracies of both the 1
st and 2
nd order
predictions are higher than that of the random guess. According to
Eq. 9 the metabolic pathway classes predicted by the 1
st and 2
nd
orders have actually covered more than 80% of all the true
metabolic pathway classes, suggesting that, of the results predicted
by the 11 orders, more attention should be paid to those by the
first two orders.
Listed in Table 2 are the accuracies by each of the 11
prediction orders for the 3,137 compounds about their involve-
ment in the 11 metabolic pathway classes using the 5-fold cross-
validation test. The highest accuracy achieved by the 1
st-order
prediction was 80.96% for the 1
st metabolic pathway class
(‘‘Carbohydrate Metabolism’’). And the results obtained by the
1
st and 2
nd prediction orders have covered 89.00% of the true
metabolic pathway classes. The second highest accuracy by the 1
st-
order prediction was 78.77% for the 11
th metabolic pathway class
(Xenobiotics Biodegradation and Metabolism), while the results
obtained by the 1
st and 2
nd prediction orders have covered 87.00%
of the true metabolic pathway classes. Both the two 1
st-order
accuracies are higher than the overall 1
st-order prediction
accuracy of 77.97%, and each of their combinations with the
2
nd-order predictions is also higher than the overall likelihood of
80.00%. As for the metabolic pathway classes with less
compounds, such as ‘‘Glycan Biosynthesis and Metabolism’’ class
that contains only 68 compounds in Group-I and 43 in Group-II
(cf. Table 1), the predicted accuracies were relatively not as good
as the others. It is anticipated that with more experimental data
are available in future for the compounds in these classes, the
corresponding prediction success rates will be improved. Overall
speaking, the aforementioned results are quite encouraging,
indicating that our approach may become a useful tool to deal
with this kind of very complicated systems.
As stated in the Method section, the interactive compounds
derived from STITCH tend to participate in the same metabolic
Predicting Compounds’ Biological Functions
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dihydrouracil with other compounds. Among the 32 interactive
compounds, most of them appear in ‘‘metabolism of cofactors and
vitamins’’ or ‘‘metabolism of other amino acids’’ or ‘‘nucleotide
metabolism’’ pathway class (cf. Table 1) just like dihydrouracil.
Dihydrouracil and uracil participate in pyrimidine metabolism
pathway (belong to ‘‘nucleotide metabolism’’), where 5,6-dihy-
drouracil and NADP+ are catalyzed by dihydropyrimidine
dehydrogenase (DPD) to form uracil and NADPH+H+ [14,27].
They are also co-mentioned in many PubMed Abstracts such as
[28,29,30,31,32,33,34,35,36,37]. Another two interactive com-
pounds - dihydrouracil and dihydrothymine share a very similar
structure, the only difference is that dihydrothymine has a methyl
at the 5th position of the hexatomic ring while dihydrouracil has
not [38]. According to the prediction criteria, when dihydrouracil
was treated as a query compound, the first three order predicted
metabolic pathways that it participates in are ‘‘nucleotide
metabolism’’, ‘‘metabolism of cofactors and vitamins’’ and
‘‘metabolism of other amino acids’’, respectively, which are
consistent with the true metabolic pathways that it is involved in.
Predicted results for the compounds with unknown
metabolic pathway
Encouraged by the quite promising results obtained by the 5-
fold cross-validation test on the benchmark dataset of the 3,137
compounds, we applied the method to the 5,549 compounds
whose metabolic pathways are unknown as mentioned in the
Materials and Methods section. The predicted results thus
obtained are given in Table S1. As discussed above, we selected
the metabolic pathway classes obtained by the 1
st and 2
nd order
predictions for these compounds, in hoping that the information
thus obtained may provide useful clues for further investigations.
Actually, it is interesting to see that many of our predicted results
have proved to be reasonable according to the reports from other
investigators. For example, N-acetylgalactosamine 4-sulfate and its
interactive compounds with pathway information are shown in
Table 4. N-acetylgalactosamine 4-sulfate can bind to sulfate,
glucuronic acid, galactose, xylose, fucose, Na(+), glycerol, and
phosphate to form complex to perform the biological function
[39]. In PubMed Abstracts, N-acetylgalactosamine 4-sulfate is co-
mentioned with sulfate [40], glucuronic acid [41], galactose [42],
39-phospho.pho. [43], sugar-1-phosph. [44], UDP-GlcNAc [45],
indole-3-glyce. [46], N-acetyl-D-glucosamine [47], and GDP-
mannose [44]. Besides, N-acetylgalactosamine 4-sulfate and N-
acetyl-D-glucosamine share a similar structure and the difference
is that N-acetylgalactosamine 4-sulfate has a sulfate at the position
4 of the ring while N-acetyl-D-glucosamine has not [38]. From
these evidences, N-acetylgalactosamine 4-sulfate is supposed to
participate in the same metabolic pathways as its interactive
compounds. It can be seen from Table 4 that most of the
interactive compounds of N-acetylgalactosamine 4-sulfate belong
to the 1
st and 2
nd metabolic pathway classes. By considering all the
interactions and the interaction confidence scores, it was predicted
that Carbohydrate Metabolism (the 1
st class) and Energy
Metabolism (the 2
nd class) would be the possible metabolic
Figure 1. Illustration to show the accuracy by each of the 11 order predictions for the 3,137 compounds by the 5-fold cross-
validation. It can be seen from the figure that from the first order to the last one, the 11 accuracies form a download-slope curve.
doi:10.1371/journal.pone.0029491.g001
Table 2. The accuracy predicted by each of the 11 orders for
the metabolic pathway classes of the 3,137 compounds by
the 5-fold cross-validation test.
Class
code Accuracy (%) predicted by each order
1
st 2
nd 3
rd 4
th 5
th 6
th 7
th 8
th 9
th 10
th 11
th
1 80.96 8.38 5.08 1.78 1.02 1.27 0.25 1.02 0.00 0.25 0.00
2 31.67 30.00 18.33 7.50 4.17 3.33 0.00 3.33 0.00 0.83 0.83
3 73.89 6.27 6.27 4.44 1.57 2.61 2.35 0.52 0.52 1.31 0.26
4 65.15 11.36 6.82 5.30 3.03 1.52 2.27 0.00 4.55 0.00 0.00
5 61.70 19.88 10.97 5.38 1.04 0.83 0.21 0.00 0.00 0.00 0.00
6 29.87 27.27 11.69 11.69 5.19 5.19 3.90 3.25 1.95 0.00 0.00
7 20.93 25.58 11.63 9.30 6.98 4.65 2.33 4.65 0.00 2.33 11.63
8 61.17 17.15 9.39 4.21 3.24 2.91 0.97 0.32 0.32 0.32 0.00
9 74.35 8.42 4.01 3.41 1.20 1.20 2.20 2.40 1.00 1.20 0.60
10 68.98 8.67 4.62 3.66 5.01 4.24 1.54 1.54 0.77 0.58 0.39
11 78.77 8.42 5.09 2.81 2.63 1.40 0.35 0.35 0.18 0.00 0.00
Overall 77.97 14.19 8.07 4.88 2.93 2.55 1.43 1.28 0.70 0.57 0.38
See Table 1 for the numbers-distribution of the 3,137 compounds among the
11 metabolic pathway classes.
doi:10.1371/journal.pone.0029491.t002
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Actually, as a carbohydrate, N-acetylgalactosamine 4-sulfate reacts
with Chondroitin 4-sulfate to form hydrogen oxide and G12336
(i.e. (GalNAc)2(GlcA)1(S)2), one kind of glycan which can
participate in Carbohydrate and Energy Metabolism. Therefore,
N-acetylgalactosamine 4-sulfate may also participate in Carbohy-
drate and Energy Metabolism. Another example is that cyclopro-
pylamine in Table 4 has 23 interactive compounds with known
pathway information. Cyclopropylamine, cyanuric acid, ammo-
nia, N-cyclopropylammelide, c0761, hydroxyl radicals are in the
same pathway - N-cyclopropylmelamine degradation [48,49],
where N-cyclopropylmelamine first reacts with hydrogen oxide to
form N-cyclopropylammeline and ammonia, and then N-cyclo-
propylammeline also reacts with hydrogen oxide to form N-
cyclopropylammelide and ammonia. After that, N-cyclopropy-
lammelide reacts with hydrogen oxide to form cyanuric acid,
cyclopropylamine and hydroxyl radicals. Finally, cyanuric acid is
transformed into hydrogen oxide and ammonia through cyanurate
degradation. Cyanuric acid, N-cyclopropylammelide, and c0761
are all in the 11
th pathway class. Therefore, cyclopropylamine may
also belong to the 11
th pathway class (Xenobiotics Biodegradation
and Metabolism). For other interactive compounds, they are co-
mentioned with cyclopropylamine in PubMed Abstracts, such as
polyethylene [50], 1-aminocyclopropane-1-carboxylic acid [51],
cyclopropanecarboxylic acid [52], 3-hydroxyphenylacetic acid
[53], and acetophenone [54]. In Table 4, most of the interactive
compounds of cyclopropylamine belong to the 11
th metabolic
pathway classes. According to above analysis, cyclopropylamine is
suggested to participate in the Xenobiotics Biodegradation
Metabolism, which was the 1
st-order predicted class for cyclopro-
pylamine by our method. Accordingly, it is quite reasonable to
expect that our method may provide useful information for further
Table 3. Interactions of dihydrouracil with other compounds in the benchmark dataset of Group-II.
KEGG ligand Name
Code of
Metabolic
pathway class KEGG ligand Name
Code of Metabolic
pathway class
Interaction
confidence
C00429 Dihydrouracil 4, 6, 8 C00106 Uracil 4, 6, 8 0.981
C00429 Dihydrouracil 4, 6, 8 C02642 N-carbamoyl-be. 4, 6, 8 0.945
C00429 Dihydrouracil 4, 6, 8 C00006 NADP 2, 6, 8 0.921
C00429 Dihydrouracil 4, 6, 8 C00005 NADP(H) 2, 6 0.902
C00429 Dihydrouracil 4, 6, 8 C00001 Hydroxyl radic. 2, 8 0.899
C00429 Dihydrouracil 4, 6, 8 C00013 Pyrophosphate 2 0.899
C00429 Dihydrouracil 4, 6, 8 C00119 Phosphoribosyl. 1, 4, 5 0.899
C00429 Dihydrouracil 4, 6, 8 C00906 Dihydrothymine 4 0.855
C00429 Dihydrouracil 4, 6, 8 C00178 Thymine 4 0.814
C00429 Dihydrouracil 4, 6, 8 C07649 5-fluorouracil 11 0.744
C00429 Dihydrouracil 4, 6, 8 C00099 Beta-alanine 1, 4, 6, 8 0.650
C00429 Dihydrouracil 4, 6, 8 C00380 Cytosine 4 0.551
C00429 Dihydrouracil 4, 6, 8 C00262 Hypoxanthine 4 0.436
C00429 Dihydrouracil 4, 6, 8 C00299 Uridine 4 0.433
C00429 Dihydrouracil 4, 6, 8 C00295 Orotic acid 4 0.386
C00429 Dihydrouracil 4, 6, 8 C05145 Beta-aminoisob. 4 0.362
C00429 Dihydrouracil 4, 6, 8 C02067 Pseudouridine 4 0.353
C00429 Dihydrouracil 4, 6, 8 C00881 Deoxycytidine 4 0.350
C00429 Dihydrouracil 4, 6, 8 C00147 Adenine 4, 9 0.308
C00429 Dihydrouracil 4, 6, 8 C05100 Beta-ureidoiso. 4 0.286
C00429 Dihydrouracil 4, 6, 8 C03056 2,6-dihydroxyp. 8 0.274
C00429 Dihydrouracil 4, 6, 8 C02565 N-methylhydant. 5 0.272
C00429 Dihydrouracil 4, 6, 8 C00337 Dihydroorotate 4 0.262
C00429 Dihydrouracil 4, 6, 8 C00757 Berberine 10 0.252
C00429 Dihydrouracil 4, 6, 8 C00222 Malonate semia. 1, 11, 6 0.218
C00429 Dihydrouracil 4, 6, 8 C12650 Capecitabine 11 0.214
C00429 Dihydrouracil 4, 6, 8 C12673 Tegafur 11 0.210
C00429 Dihydrouracil 4, 6, 8 C00522 Pantoate 8 0.207
C00429 Dihydrouracil 4, 6, 8 C00864 Pantothenic ac. 6, 8 0.205
C00429 Dihydrouracil 4, 6, 8 C11736 FUdR 11 0.199
C00429 Dihydrouracil 4, 6, 8 C00366 Uric acid 4 0.167
C00429 Dihydrouracil 4, 6, 8 C00219 Arachidonic ac. 3 0.154
See Table 1 for the code of the metabolic pathway class.
doi:10.1371/journal.pone.0029491.t003
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Application and improvement
As indicated by the above discussion and analysis, the results
derived from the 1
st and 2
nd order predictions should be
considered as the candidates for the metabolic pathway classes
with which the query compound may be involved. In view of this,
biochemical experiments should be conducted by mainly focusing
on the targets predicted by the 1
st and 2
nd order predictions. The
results obtained by the last five order predictions can be ignored
due to their very low likelihood (,2%). Consequently, the current
prediction method can provide useful clues for further validation
by experiments and expedite the research progress by prioritizing
the targets concerned.
It is instructive to note that for the 4,366 compounds in Group-I
of Table 1, there are still 1,229 compounds that can not be
processed by the current method due to lack of the interaction
Table 4. Interactions of N-acetylgalactosamine 4-sulfate and cyclopropylamine with other compounds whose metabolic pathway
classes are known.
KEGG Ligand Name KEGG LigandName
Code of
Metabolic
pathway class
Interaction
Confidence
C16265 N-acetylgalactosamine 4-sulfate C00059 sulfate 2, 4, 5 0.956
C16265 N-acetylgalactosamine 4-sulfate C00333 glucuronic acid 1 0.931
C16265 N-acetylgalactosamine 4-sulfate C15923 galactose 1 0.904
C16265 N-acetylgalactosamine 4-sulfate C01508 xylose 1 0.9
C16265 N-acetylgalactosamine 4-sulfate C01721 fucose 1 0.899
C16265 N-acetylgalactosamine 4-sulfate C01330 Na(+) 2 0.899
C16265 N-acetylgalactosamine 4-sulfate C00116 glycerol 1, 3 0.899
C16265 N-acetylgalactosamine 4-sulfate C00009 phosphate 2, 7 0.899
C16265 N-acetylgalactosamine 4-sulfate C00053 39-phospho.pho. 2, 4, 7 0.47
C16265 N-acetylgalactosamine 4-sulfate C02591 sugar-1-phosph. 1 0.312
C16265 N-acetylgalactosamine 4-sulfate C01170 UDP-GlcNAc 1 0.27
C16265 N-acetylgalactosamine 4-sulfate C03506 indole-3-glyce. 10, 5 0.256
C16265 N-acetylgalactosamine 4-sulfate C01132 N-acetyl-D-glucosamine 1 0.235
C16265 N-acetylgalactosamine 4-sulfate C00096 GDP-mannose 1, 7 0.183
C14150 cyclopropylamine C06554 cyanuric acid 11 0.918
C14150 cyclopropylamine C00014 ammonia 2, 4, 5, 6 0.907
C14150 cyclopropylamine C14149 N-cyclopropylammelide 11 0.899
C14150 cyclopropylamine C14148 c0761 11 0.899
C14150 cyclopropylamine C00001 hydroxyl radicals 2, 8 0.899
C14150 cyclopropylamine C00969 reuterin 3 0.378
C14150 cyclopropylamine C06547 polyethylene 11, 5 0.347
C14150 cyclopropylamine C01234 1-aminocyclopropane-1-carboxylic acid 1, 5 0.29
C14150 cyclopropylamine C00218 methylamine 2 0.29
C14150 cyclopropylamine C16267 cyclopropanecarboxylic acid 11 0.286
C14150 cyclopropylamine C16318 methyl jasmonate 3 0.273
C14150 cyclopropylamine C11512 methyl jasmonate 3 0.273
C14150 cyclopropylamine C05593 3-hydroxyphenylacetic acid 11, 5 0.267
C14150 cyclopropylamine C00261 benzaldehyde 11 0.238
C14150 cyclopropylamine C01054 2,3-oxidosqualene 3 0.236
C14150 cyclopropylamine C01013 3-hydroxypropionate 1, 6 0.224
C14150 cyclopropylamine C01471 acrolein 11 0.208
C14150 cyclopropylamine C01746 calcium channel blocker 10 0.205
C14150 cyclopropylamine C00571 cyclohexylamine 11 0.205
C14150 cyclopropylamine C00144 guanosine monophosphate 4 0.205
C14150 cyclopropylamine C00903 cinnamaldehyde 10 0.171
C14150 cyclopropylamine C07113 acetophenone 11 0.168
C14150 cyclopropylamine C01724 lanosterol 3 0.152
See Table 1 for the code of the metabolic pathway class.
doi:10.1371/journal.pone.0029491.t004
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expected that the problem can be solved by collecting as much
chemical-chemical interaction information as possible from
STITCH, which is a large-scale and well-maintained resource in
chemical biology, including the interactions information for over
2.5 million proteins and over 74,000 small molecules in 630
organisms. With the continuous increase of the interactions
information, the performance of our method will be further
improved.
Conclusion
Based on the chemical-chemical interactions information, a
multi-target model was proposed for identifying the metabolic
pathway classes with which a query compound is involved. Since
some compounds may be involved with more than one metabolic
pathway class, our method is featured by the capacity able to
provide a series of potential metabolic pathway classes for each of
the query compounds investigated, instead of only one metabolic
pathway class. It is anticipated that our method may become a
useful tool in helping annotate the compound for their biological
functions.
Supporting Information
Table S1 Each order predicted metabolic pathway class for the
collected 5,549 compounds without known metabolic pathway
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